Journal of Psychosomatic Research
Volume 70, Issue 1 , Pages 99-109 , January 2011

Instruments to measure sexual dysfunction in community and psychiatric populations

  • Sakina J. Rizvi

      Affiliations

    • Department of Psychiatry, University Health Network, Toronto, Ontario, Canada
    • Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada
    • Department of Neuroscience, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Niette W. Yeung

      Affiliations

    • Department of Psychiatry, University Health Network, Toronto, Ontario, Canada
    • ,
  • Sidney H. Kennedy

      Affiliations

    • Department of Psychiatry, University Health Network, Toronto, Ontario, Canada
    • Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author. University Health Network, Room 222, Eaton North Wing 8th Floor, 200 Elizabeth Street, Toronto, ON, Canada M5G 2C4. Tel.: +1 416 340 3888; fax: +1 416 340 4198.

Received 23 July 2009 ,Revised 6 May 2010 ,Accepted 11 May 2010.

References 

  1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–544
  2. Moreira , Brock G, Glasser DB, Nicolosi A, Laumann EO, Paik A, et al. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Int J Clin Pract. 2005;59:6–16
  3. Moreira , Glasser DB, Nicolosi A, Duarte FG, Gingell C GSSAB Investigators' Group. Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU Int. 2008;101:1005–1011
  4. Angst J. Sexual problems in healthy and depressed persons. Int Clin Pharmacol. 1998;13:S1–4
  5. Casper RC, Redmond DE, Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Arch Gen Psychiatry. 1985;42:1098–1104
  6. Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the “true” prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact?. J Sex Med. 2008;5:777–787
  7. Chen KC, Yang YK, Lee IH, Yeh TL, Lu RB, Chen PS. Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan. Depression and Anxiety. 2008;25:56–62
  8. Williams VS, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry. 2006;67:204–210
  9. Nicolosi A, Laumann EO, Glasser DB, Brock G, King R, Gingell C. Sexual activity, sexual disorders and associated help-seeking behavior among mature adults in five Anglophone countries from the Global Survey of Sexual Attitudes and Behaviors (GSSAB). J Sex Marital Ther. 2006;32:331–342
  10. Bonierbale M, Lançon C, Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin. 2003;19:114–124
  11. Rush AJ, Pincus HA, First MB, Blacker D, Endicott J, Keith SJ, et al. Handbook of psychiatric measures. Washington (DC): American Psychiatric Association; 2000;
  12. Derogatis LR. Derogatis Sexual Functioning Inventory (DSFI): preliminary scoring manual. Baltimore (Md): Clinical Psychometric Research; 1975;
  13. Derogatis LR, Melisaratos N. The DSFI: a multidimensional measure of sexual functioning. J Sex Marital Ther. 1979;5:244–281
  14. Zinreich ES, Derogatis LR, Herpst J, Auvil G, Piantadosi S, Order SE. Pre and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1990;19:729–732
  15. Nowinski JK, LoPiccolo J. Assessing sexual behaviors in couples. J Sex Marital Ther. 1979;5:225–243
  16. Schover LR, Jensen SB. Sexuality and chronic illness: a comprehensive approach. New York: Guiltford Press; 1988;
  17. Schover LR, LoPiccolo J. Treatment effectiveness for dysfunctions of sexual desire. J Sex Marital Ther. 1982;8:179–197
  18. Trudel G, Ravart G, Matte B. The use of the multiaxial diagnostic system for sexual dysfunctions in the assessment of hypoactive sexual desire. J Sex Marital Ther. 1993;19:123–130
  19. Jodoin M, Bergeron S, Khalifé S, Dupuis MJ, Desrochers G, Leclerc B. Male partners of women with provoked vestibulodynia: attributions for pain and their implications for dyadic adjustment, sexual satisfaction, and psychological distress. J Sex Med. 2008;5:2862–2870
  20. Creti L, Fichten CS, Libman E, Kalogeropoulos D, Brender W. A global score for the “Sexual History Form” and its effectiveness. In: Paper Presented At The 21st annual convention of the Association for Advancement of Behavior Therapy. Boston. 1987;
  21. Creti L, Fichten CS, Libman E, Amsel R, Brender W. Female sexual functioning: a global score for Nowinski and LoPiccolo's Sexual History Form. In: Paper presented at the annual convention of the Canadian Psychological Association. Montreal, Quebec. 1988;
  22. Libman E, Fichten CS, Creti L, Weinstein N, Amsel R, Brender W. Transurethral prostatectomy: differential effects of age category and presurgery sexual functioning on post-prostatectomy sexual adjustment. J Behav Med. 1989;12:469–485
  23. Creti L, Libman E. Cognitions and sexual expression in the aging. J Sex Marital Ther. 1989;15:83–101
  24. LoPiccolo J, Steger JC. The sexual interaction inventory: a new instrument for assessment of sexual dysfunction. Arch Sex Behav. 1974;3:585–595
  25. LoPiccolo J, Heiman JR, Hogan DR, Roberts CW. Effectiveness of single therapists versus cotherapy teams in sex therapy. J Consult Clin Psychol. 1985;53:287–294
  26. Morokoff PJ, LoPiccolo J. A comparative evaluation of minimal therapist contact the 15-session treatment for female orgasmic dysfunction. J Consult Clin Psychol. 1986;54:294–300
  27. Rust J, Golombok S. The GRISS: a psychometric instrument for the assessment of sexual dysfunction. Arch Sex Behav. 1986;15:157–165
  28. Clayton A, Pradko J, Croft H, Montano CB, Leadbetter RA, Bolden-Watson C, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 2002;63:357–366
  29. Baldwin D. Depression and sexual dysfunction. Br Med Bull. 2001;57:81–99
  30. Haberfellner EM. A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials. Pharmacopsychiatry. 2007;40:173–182
  31. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 2000;26:25–40
  32. Byerly MJ, Nakonezny PA, Fisher R, Magouirk B, Rush JA. An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophr Res. 2006;81:311–316
  33. Soykan A. The reliability and validity of Arizona sexual experiences scale in Turkish ESRD patients undergoing hemodialysis. Int J Impot Res. 2004;16:531–534
  34. Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 1997;33:731–745
  35. Clayton AH, McGarvey EL, Clavet GJ, Piazza L. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ). Psychopharmacol Bull. 1997;33:747–753
  36. Keller A, McGarvey EL, Clayton AH. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14). J Sex Marital Ther. 2006;32:43–52
  37. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001;62(Suppl 3):10–21
  38. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  39. Montejo AL, Rico-Villademoros F. Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther. 2008;34:227–239
  40. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 2000;61:276–281
  41. Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S. Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry. 2006;51:234–242
  42. Kennedy SH, Rizvi S, Fulton K, Rasmussen J. A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psyhchiatry. 2008;28:329–333
  43. Rizvi S, Kennedy SH, Ellis J, Ravindran L, Fulton K, Panjwani Z, et al. The Sex Effects Scale: validation in a healthy population. J Sex Mar Ther. 2010;[in press]
  44. Rizvi S, Kennedy SH, Fulton K, Panjwani Z, Quilty LC. Sexual dysfunction in depression: validation of the Sex-FX Scale in a healthy and depressed population. In: Presented at the Autumn Meeting for the International Society for CNS Clinical Trials and Methodology. Toronto. 2008;
  45. Hoon EF, Joon PW, Wincze JP. An inventory for the measurement of female sexual arousability: the SAI. Arch Sex Behav. 1976;5:269–274
  46. Hoon EF, Chambless D. Sexual Arousability Inventory (SAI) and Sexual Arousability Inventory-Expanded (SAI-E). In:  Davis CM,  Yarber CL editor. Sexually related measures: a compendium. Syracuse (NY): Graphic Publishing; 1988;p. 308–313
  47. Wincze JP, Albert A, Bansal S. Sexual arousal in diabetic females: physiological and self-report measures. Arch Sex Behav. 1993;22:587–601
  48. Morrell MJ, Sperling MR, Stecker M, Dichter MA. Sexual dysfunction in partial epilepsy: a deficit in physiologic sexual arousal. Neurology. 1994;44:243–247
  49. Dantas Cde R, Banzato CE. Inter-rater reliability and factor analysis of the Brazilian version of the Schedule for the Assessment of Insight: Expanded Version (SAI-E). Rev Bras Psiquiatr. 2007;29:359–362
  50. Symonds T, Boolell M, Quirk F. Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther. 2005;31:385–397
  51. Abraham L, Symonds T, Morris MF. Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction. Int Soc Sex Med. 2008;5:595–601
  52. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American urological association symptom index for benign prostatic hyperplasic. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549–1557
  53. O'Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA, et al. A brief male sexual function inventory for urology. Urology. 1995;46:697–706
  54. Rosen RC, Catania J, Pollack L, Althof S, O'Leary M, Seftel AD. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation. Urology. 2004;64:777–782
  55. Rosen RC, Catania JA, Althof SE, Pollack LM, O'Leary M, Seftel AD, et al. Development and validation of four-item version of male sexual health questionnaire to assess ejaculatory dysfunction. J Urology. 2007;69:805–809
  56. Cappelleri JC, Rosen RC, Smith MD, Quirk F, Maytom MC, Mishra A, et al. Some developments on the International Index of Erectile Function (IIEF). Drug Inf J. 1999;33:179–190
  57. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–830
  58. Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226–244
  59. Wiltink J, Hauck EW, Phadayanon M, Weidner W, Beutel ME. Validation of the German version of the International Index of Erectile Function (IIEF) in patients with erectile dysfunction, Peyronie's disease and controls. Int J Impot Res. 2003;15:192–197
  60. Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, et al. Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007;52:565–573
  61. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav. 1994;23:627–643
  62. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208
  63. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther. 2003;29:39–46
  64. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28:317–330
  65. Derogatis LR, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med. 2008;5:357–364
  66. Derogatis L, Rust J, Golombok S, Bouchard C, Nachtigall L, Rodenberg C, et al. Validation of the profile of female sexual function (PFSF) in surgically and naturally menopausal women. J Sex Marital Ther. 2004;30:25–36
  67. Rust J, Derogatis L, Rodenberg C, Koochaki P, Schmitt S, Golombok S. Development and validation of a new screening tool for hypoactive sexual desire disorder: the Brief Profile of Female Sexual Function (B-PFSF). Gynecol Endocrinol. 2007;23:638–644
  68. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med. 2006;3:212–222
  69. Graziottin A, Koochaki , Rodenberg CA, Dennerstein L. The prevalence of hypoactive sexual desire disorder in surgically menopausal women: an epidemiological study of women in four European countries. J Sex Med. 2009;6:2143–2153
  70. Kronawitter D, Gooren LJ, Zollver H, Oppelt PG, Beckmann MW, Dittrich R, et al. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. Eur J Endocrinol. 2009;161:363–368
  71. Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, Migliardi M, et al. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecol Endocrinol. 2010;26:404–412
  72. Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med. 2002;41:277–291
  73. Sills T, Wunderlich G, Pyke R, Segraves RT, Leiblum S, Clayton A, et al. The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder. J Sex Med. 2005;2:801–818
  74. Clayton AH, Segraves RT, Leiblum S, Basson R, Pyke R, Cotton D, et al. Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder. J Sex Marital Ther. 2006;32:115–135
  75. Kennedy SH, Rizvi S. Sexual dysfunction, depression and the impact of antidepressants. J Clin Psychopharmacol. 2009;29:157–164

PII: S0022-3999(10)00226-6

doi: 10.1016/j.jpsychores.2010.05.009

Journal of Psychosomatic Research
Volume 70, Issue 1 , Pages 99-109 , January 2011

Article Tools